Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Investigate the Protective Effects of Glucagon-like Peptide-1 (GLP-1) in Patients Undergoing Elective Angioplasty and Stenting (GOLD-PCI)

NCT02127996 is registered in ClinicalTrials.gov with Papworth Hospital NHS Foundation Trust as lead sponsor.

NCT NCT02127996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02127996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Investigate the Protective Effects of Glucagon-like Peptide-1 (GLP-1) in Patients Undergoing Elective Angioplasty and Stenting (GOLD-PCI)
Lead sponsor
Papworth Hospital NHS Foundation Trust
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2015
Completion date
July 31, 2021
Enrollment
193 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angina pectoris, coronary heart disease, myocardial infarction, reperfusion injury